Institut National De La Sante Et De La Recherche Medicale

Paris, Île-de-France Doing business as Inserm

UEI
EJKSXFA4T326
CAGE
FA6Z9
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Government
Entity structure
Country - Foreign Government
Corporate family
SAM.gov registration date
Physical address
101 Rue de Tolbiac, 75013 Paris, France
Website
inserm.fr
Founded
1964
Employees
5K-10K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
NOTCH3 signaling in small-artery-diseases R01NS054122 National Institutes of Health $330,336
Molecular basis of uterine cellular interactions R01CA112686 National Institutes of Health $230,408

Grant subawards

Prime recipient Prime award Amount Awarded
The Regents Of The University Of California Function and mechanism of EndoU R01GM152548 $48,870

Similar vendors

About the company

Institut National De La Sante Et De La Recherche Medicale (Inserm) is a French government research organization dedicated to biomedical research and human health. As the only public research institution in France focused solely on human health, Inserm plays a crucial role in advancing medical knowledge and improving healthcare outcomes. Through its various subsidiaries and regional delegations, Inserm engages in a wide range of research activities funded by U.S. federal grant awards. These activities span diverse areas of biomedical science, including neuroscience, cardiovascular research, cancer biology, infectious diseases, and public health. Inserm's involvement in U.S.-funded research demonstrates its commitment to international scientific collaboration and its recognized expertise in cutting-edge biomedical research.

Inserm has received both prime federal grant awards and numerous sub-awards, collaborating with prestigious American institutions such as the National Institutes of Health, Defense Health Agency, and leading universities. Notable research projects include studying the cellular origins of bone manifestations in Neurofibromatosis Type 1, investigating morphine-responsive neurons in the medial habenula, and developing highly granular cell atlases of non-human primates. Inserm's expertise is particularly evident in specialized areas such as electrophysiology, phosphoproteomic analyses, and advanced imaging techniques. For instance, Inserm teams have contributed to the development of real-time 2D and 3D focused ultrasound imaging, implantable ultrasound arrays, and targeted multi-photon 3D illumination for voltage imaging in living subjects. The organization has also been involved in critical research on COVID-19 vaccine safety monitoring, cannabis use disorder treatments, and innovative approaches to understanding and treating conditions like acute lymphoblastic leukemia, Alzheimer's disease, and CADASIL. These diverse projects, funded through programs such as the Military Medical Research and Development program and various NIH initiatives, underscore Inserm's significant role in advancing biomedical research and its potential impact on both military and public health outcomes.

Quick answers

Is Institut National De La Sante Et De La Recherche Medicale registered in SAM.gov?

Yes. Institut National De La Sante Et De La Recherche Medicale's SAM.gov registration is active through December 17, 2026.

What is Institut National De La Sante Et De La Recherche Medicale's CAGE code?

Institut National De La Sante Et De La Recherche Medicale's CAGE code is FA6Z9, and its Unique Entity ID (UEI) is EJKSXFA4T326.

What is Institut National De La Sante Et De La Recherche Medicale's most recent federal award?

Institut National De La Sante Et De La Recherche Medicale's most recent federal grant award is NOTCH3 signaling in small-artery-diseases (R01NS054122), from National Institutes of Health, on February 1, 2006.

On GovTribe

See Institut National De La Sante Et De La Recherche Medicale's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe